Miv Therapeutics, Inc. (IVT) Reports Q3 EPS of $0.06

Miv Therapeutics, Inc. (NYSE: IVT) reported Q3 EPS of $0.06. Revenue for the quarter came in at $50.89 million.

GUIDANCE:

Miv Therapeutics, Inc. sees FY2021 EPS of ($0.20)-($0.16).

For earnings history and earnings-related data on Miv Therapeutics, Inc. (IVT) click here.

You May Also Be Interested In

• NIO Inc. (NIO) Tops Q2 EPS by 33c; offers guidance
• TDS drops bid for Array Digital Infrastructure minority shares
• Yext, Inc. (YEXT) Tops Q2 EPS by 4c